Better medicines for babies, children and young people through a pan-European clinical trial network
c4c will use a coordinated approach to deliver high quality “regulatory grade” clinical trials in:
A project under the EU Innovative Medicines Initiative (IMI)
The c4c research network brings together pharmaceutical companies, paediatric national networks as well as EU multinational sub-specialty networks, large patient advocacy groups, children’s hospitals and other public research organisations from across Europe.
The project consortium is a novel collaboration between academic and private sectors that includes 33 academic and 10 industry partners from 20 European countries, as well as more than 50 third parties and around 500 affiliated partners.
The c4c consortium members
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.